Biotech Blueprint
Biotech Blueprint
Podcast Description
Connecting with biotech, pharma, and academic professionals to explore the latest in science, startups, market trends, and breakthroughs.
For more content, please subscribe to biotechblueprint.substack.com.
Podcast Insights
Content Themes
The podcast focuses on trends and challenges within the biotech sector, including topics such as startup ecosystems, emerging market trends, AI applications in drug discovery, and the latest scientific breakthroughs. For example, episodes cover the development of mRNA cancer vaccines and the implications of recent market layoffs on the industry.
Connecting with biotech, pharma, and academic professionals to explore the latest in science, startups, market trends, and breakthroughs.
For more content, please subscribe to biotechblueprint.substack.com.
Subscribe to Biotech Blueprint for free at biotechblueprint.com
In the latest joint podcast episode by Biotech Blueprint × Biotech Capital Compass, we zoom in on Moderna and where the company stands in 2026. We work through the Q1 earnings beat, the unprecedented FDA refusal-to-file on mRNA-1010, the CMV Phase 3 failure, the Vertex cystic fibrosis wind down, and the individualized neoantigen therapy (INT) program that has moved to the center of the pipeline. The short companion piece below picks up one thread from the conversation, which is the pattern across Moderna’s wins and losses, and what it suggests about where the platform actually works.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.